Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05690776

PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband

Conditions: Rotator Cuff Tears, Rotator Cuff Injuries

Sex: All
Ages: 18 Years – N/A
Enrollment: 109
Sponsor: Zimmer Biomet

Location: France

Summary

The study is a multicenter, retrospective and prospective, non-randomized, noncontrolled, and consecutive series post-market study. The purpose of this study is collect data confirming safety, performance and clinical benefits of the Quattro® X Suture Anchor with BroadBand™ Tape and Instruments when used in rotator cuff repair.The primary endpoint of this study is the assessment of performance by analyzing soft tissue to bone healing in the shoulder (rotator cuff). Healing will be assessed by the investigator using PROMs and clinical outcomes of the patient. The clinical benefit will be assessed by functional outcomes measured using standard and well-established scoring systems (e.g. Constant & Murley and EQ-5D-5L) at 1 year post-operative.The safety will be assessed by monitoring the incidence and frequency of device- and/or procedure-related adverse events.

Eligibility Criteria

Inclusion Criteria:Subject treated with the Quattro® X Suture Anchor with BroadBand™ Tape for rotator cuff repair;Older than 18 years and skeletally mature;Willing and able to comply with the study procedures;Subject is capable of understanding the doctor's explanations, following his instructions and is able to participate in the follow-up program;Subject is able to read and understand the ICF and has voluntarily provided written informed consent.Exclusion Criteria:Presence of infection;Insufficient or immature bone;Insufficient blood supply or previous infections which may hinder the healing process;Foreign body sensitivity;Subject is vulnerable (prisoner, mentally incompetent or unable to understand what participation to the study entails, a known alcohol or drug abuser, anticipated to be non-compliant);The subject is unwilling or unable to give consent or to comply with the follow-up program;Subject meets any contraindications of the appropriate Instruction for Use.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05690776). StuddyBuddy aggregates publicly available trial information.